Neuren Pharmaceuticals Limited
NURPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $15,031 | $134,027 | $8,016 | $109,276 |
| Dep. & Amort. | $11 | $11 | $11 | $11 |
| Deferred Tax | $0 | $0 | $0 | -$1,915 |
| Stock-Based Comp. | $512 | $466 | $765 | $1,893 |
| Change in WC | $155,201 | -$161,334 | $3,749 | -$5,585 |
| Other Non-Cash | -$42,449 | $36,096 | -$33,077 | $36,367 |
| Operating Cash Flow | $128,306 | $9,266 | -$20,536 | $140,047 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$7 | -$3 | -$22 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$211,445 |
| Inv. Sales/Matur. | $0 | $0 | $843 | $0 |
| Other Inv. Act. | -$85,568 | $3,301 | $0 | $47,286 |
| Investing Cash Flow | -$85,573 | $3,294 | $840 | -$164,181 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1,651 | $2,522 |
| Stock Repurch. | -$39,573 | -$10,426 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,365 | $0 | $1,651 | $2,522 |
| Financing Cash Flow | -$38,208 | -$10,426 | $1,651 | $2,522 |
| Forex Effect | -$1,772 | -$1,552 | $3,522 | $317 |
| Net Chg. in Cash | $5,906 | -$2,571 | $2,571 | -$21,295 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $2,571 | $0 | $38,389 |
| End Cash | $5,906 | $0 | $2,571 | $17,094 |
| Free Cash Flow | $128,301 | $9,259 | -$20,539 | $140,025 |